VLTO Forensic analysis

BUYConviction: 7/10Price: $86.4710-Q
Loading technical data…

Price Targets (12m)

Bull Case
$105.00
+21.4% from current
Base Case
$95.00
+9.9% from current
Bear Case
$78.00
-9.8% from current

Detailed research

PART 1: TRADING EXECUTION

Trading Setup & Entry Strategy

VLTO is currently exhibiting a BEARISH_DOWNTREND with a significant gap to its 200-day SMA ($98.31). The stock is hovering near the lower Bollinger Band ($84.69), suggesting short-term oversold conditions, but the lack of bullish divergence in the MACD/RSI indicates no immediate trend reversal.

  • >Entry Zone: $84.50 – $85.50. We are looking for a re-test of the lower Bollinger Band. Accumulate 30% position here.
  • >Add Level: $82.00 (Psychological support/swing low). Add 40% here.
  • >Stop Loss: $79.50 (Hard stop). A breach of this level invalidates the medium-term recovery thesis.
  • >Take Profit: Target $92.00 (50-day SMA) and $98.00 (200-day SMA).
  • >Risk/Reward: ~1:2.8. Max hold: 2 weeks.

Executive Summary

VLTO ($86.47) is a high-quality compounder currently caught in a technical consolidation following recent restructuring news. Despite a solid Q1 earnings beat ($254M net earnings), the market is discounting the stock due to the 2026 Restructuring Program ($85M-$105M charges). Thesis: Buy the structural transition, as the company remains highly cash-generative with recurring revenue representing 62% of sales.


PART 2: DETAILED RESEARCH

Recent Material Events (8-K Analysis)

  • >April 28, 2026: Announcement of a major 2026 Restructuring Program targeting workforce reduction and site consolidations through 2028. Total charges estimated at $85M-$105M.
  • >Corporate Governance: Filed a corrected Certificate of Incorporation to reflect the elimination of supermajority voting requirements.

Insider Trading Activity

Recent filings (May 2026) show standard RSU/PSU vestings. No significant open-market buying or selling by C-suite executives, indicating neutrality among management regarding the current share price weakness.

Financial Health & Forensics

  • >Revenue Quality: Strong. 62% recurring revenue provides a significant moat.
  • >Cash Flow: Operations generated $182M in Q1 2026 vs $157M in Q1 2025. This is a positive delta.
  • >Red Flags: Acquisition-related goodwill increased to $3.04B (from $2.84B). We are monitoring for impairment, though none identified yet. Leverage appears manageable with $2.66B total debt.

Technical Analysis & Trade Timing

  • >Trend: The Death Cross remains a concern as the stock trades 12% below the 200-day SMA.
  • >Momentum: RSI at 44.91 shows neither extreme. The current downtrend is losing velocity, providing a tactical window to initiate long positions near the lower Bollinger Band.

Short-Term Trading Strategy (2-5 Days)

  • >Timeframe: Swing Trade (2–5 Days)
  • >Position Size: 3% of portfolio.
  • >Strategy: Wait for a test of $84.70 (lower BB). If it holds, enter 30% of target. Target 50% profit at $89.00 (near 50-day SMA).
  • >Risk: The 2026 restructuring noise may keep volatility elevated.

One-Liner Thesis: Veralto is a high-moat water infrastructure play currently penalized by transition-related restructuring costs; we view the sub-$86 level as an attractive entry for long-term compounding.